Long COVID: Symptoms and Recovery

Long COVID (Post-COVID-19 condition) is defined by the WHO as the continuation or development of new symptoms 3 months after initial COVID-19 infection, lasting at least 2 months, with no alternative explanation. It affects an estimated 10–30% of people who have had COVID-19, representing tens of millions of patients worldwide.

The most commonly reported Long COVID symptoms include: post-exertional malaise (symptoms worsen after physical or mental effort), persistent fatigue, cognitive impairment ('brain fog' — difficulty with memory, concentration, word-finding), shortness of breath, chronic cough, chest pain, palpitations, headache, sleep disturbances, anxiety and depression, and dysautonomia (abnormal heart rate and blood pressure regulation when changing posture — POTS).

Proposed mechanisms include: viral persistence in tissue reservoirs, autoimmune dysregulation (autoantibodies), reactivation of latent viruses (particularly Epstein-Barr virus), microbiome disruption, mitochondrial dysfunction, and microclots (fibrin microthrombi) impairing tissue oxygenation. Vaccination reduces but does not eliminate the risk of Long COVID following breakthrough infection.

Management is supportive and symptom-based: pacing and energy management (avoiding the push-crash cycle that worsens post-exertional malaise), rehabilitation by specialist Long COVID clinics, treatment of specific complications (anticoagulants for confirmed microclots, beta-blockers or fludrocortisone for POTS, SSRIs for mood symptoms). Research into targeted treatments is ongoing. Most patients improve gradually over 12–24 months, though some have persistent symptoms beyond this timeframe.

Related Questions